Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Anthem, Cigna merger squabbles could delay antitrust approval: WSJ

Published 05/22/2016, 01:55 PM
Updated 05/22/2016, 02:50 PM
© Reuters. The office building of health insurer Anthem is seen in Los Angeles, California

© Reuters. The office building of health insurer Anthem is seen in Los Angeles, California

WASHINGTON (Reuters) - Quarrels have broken out behind the scenes of Anthem Inc's (N:ANTM) proposed acquisition of Cigna Corp (N:CI), as the health insurers seek regulatory approval for their landmark deal, the Wall Street Journal reported on Sunday.

The newspaper said the squabbles could delay or derail antitrust approvals, though the deal does not appear to be in danger of imminent collapse.

Sources familiar with the matter confirmed the citations in the Journal story.

An Anthem spokeswoman declined to comment on the Journal report. Cigna officials were not immediately available to comment.

In a series of letters between top officials including their chief executives, the Journal said Anthem and Cigna accuse each other of violating the July merger agreement and fumbling submissions to regulators.

A key point of contention is Anthem's lawsuit against Express Scripts Holding Co (O:ESRX), a middleman for prescription drugs, according to the newspaper. The suit accuses Express Scripts of overcharging Anthem for drugs.

Cigna Chairman Isaiah Harris Jr., in an April 9 letter to Anthem's board, said the suit could hurt the prospects for regulatory approval and the combined company's value, the Journal said. Anthem responded to Cigna's board that it had alerted Cigna to the possibility of a lawsuit early in their merger talks, and that getting better prices from Express Scripts could only be beneficial, the newspaper reported.

Disclosure statements from the two companies earlier this month hinted that they had different views about when the deal would close.

In a filing with the Securities and Exchange Commission Cigna said that the deal may close in 2017, rather than in 2016 due to the complexity of the regulatory process.

© Reuters. The office building of health insurer Anthem is seen in Los Angeles, California

Anthem, meanwhile, said it had not changed its expectations on timing.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.